Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Go back to Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update
(NASDAQ: IMUX) Delayed: 13.03 -0.08 (0.61%)
Previous Close $13.11    52 Week High
Open $12.93    52 Week Low
Day High $13.28    P/E N/A 
Day Low $12.35    EPS
Volume 292,031